Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis

Medical Microbiology and Immunology

Volumn 193, Issue 1, 2004, Pages 19-25

  Dhar, Neeraj ^a   Rao, Vivek ^a   Tyagi, Anil K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Antigen 85; Mycobacteria; Recombinant BCG; Tuberculosis

Indexed keywords

ANTIGEN 85A; ANTIGEN 85C; BACTERIAL ANTIGEN; BCG VACCINE; GAMMA INTERFERON; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ANTIGEN 85A, MYCOBACTERIUM TUBERCULOSIS; ANTIGEN 85B, MYCOBACTERIUM TUBERCULOSIS; ANTIGEN 85C, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 10; RECOMBINANT PROTEIN;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; SPLEEN CELL; TH1 CELL; TUBERCULOSIS; WILD TYPE; ANIMAL; BACTERIAL GENE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; SPLEEN;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CELL CULTURE TECHNIQUES; CLONING, MOLECULAR; GENE EXPRESSION; GENES, BACTERIAL; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SPLEEN;

EID: 2342419980     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-002-0170-x     Document Type: Article

References (21)

1. Andersen P (2001) TB vaccines: progress and problems. Trends Immunol 22:160-168
2. Baldwin SL, D'Souza C, Roberts AD, Kelly BP, Frank AA, Lui MA, Ulmer JB, Huygen K, McMurray DM, Orme IM (1998) Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 66:2951-2959
3. Baldwin SL, D'Souza CD, Orme IM, Liu MA, Huygen K, Denis O, Tang A, Zhu L, Montgomery D, Ulmer JB (1999) Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tuberc Lung Dis 79:251-259
4. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS (1997) Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422
5. Bloom BR, Fine PEM (1994) The BCG experience: implications for future vaccines against tuberculosis. In Bloom BR (ed) Tuberculosis: pathogenesis, protection and control. American Society of Microbiology, Washington, DC, pp 531-557
6. Dhar N, Rao V, Tyagi AK (2000) Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis. FEMS Microbiol Lett 190:309-316
7. Dolin PJ, Raviglione MC, Kochi A (1994) Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Org 72:213-220
8. Flynn JL, Chan J, Triebold JE, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249-2254
9. Horwitz MA, Lee BW, Dillon BJ, Harth G (1995) Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 92:1530-1534
10. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S (2000) Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97:13853-13858
11. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, Drowart A, Lozes E, Vanderbussche P, Van Vooren JP, Liu MA, Ulmer JB (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2:893-898
12. Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67:1702-1707
13. Kamath AT, Groat NL, Bean AG, Britton WJ (2000) Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes. Clin Exp Immunol 120:476-482
14. Lozes E, Huygen K, Content J, Denis O, Montgomery D, Yawman AM, Vandenbussche P, Van Vooren JP, Drowart A, Ulmer JB, Liu MA (1997) Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15:830-833
15. Malin AS, Huygen K, Content J, Mackett M, Brandt L, Andersen P, Smith SM, Dockrell HM (2000) Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85. Microbes Infect 2:1677-1685
16. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
17. Ohara N, Yamada T (2001) Recombinant BCG vaccines. Vaccine 19:4089-4098
18. Ohara N, Matsuoka M, Nomaguchi H, Naito M, Yamada T (2000) Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guerin (BCG). Vaccine 18:1294-1297
19. Ohara N, Matsuoka M, Nomaguchi H, Naito M, Yamada T (2001) Protective responses against experimental Mycobacterium leprae infection in mice induced by recombinant Bacillus Calmette-Guerin over-producing three putative protective antigen candidates. Vaccine 19:1906-1910
20. Tanghe A, Denis O, Lambrecht B, Motte V, Berg T van den, Huygen K (2000) Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect Immun 68:3854-3860
21. Wiker HG, Harboe M (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56:648-661